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tively resistant. Comparison of the disposition and effects
Animal studies provide more direct and quantifiable evidence of estrogens in these two strains should provide insights for a causal role of estrogens in tumorigenesis (reviewed in into the mechanisms of estrogen carcinogenicity. We have refs 8,9) . E1, E2 and the stilbene estrogen diethylstilbestrol begun this investigation by comparing the metabolism of induce mammary gland tumors in both rats and mice and [ 3 H]17β-estradiol (E2) by liver microsomes prepared from estriol (E3) is also a mammary carcinogen in mice. The female rats from each strain. Both strains produce estrone synthetic steroids norethynodrel and mestranol are mammary (E1) as the major product at E2 concentrations >1 µM, carcinogens in rats and dogs, respectively. In addition to these with smaller amounts of 2-hydroxy-E2 formed. As the E2 effects in mammary gland, estrogens are also carcinogenic in concentration is decreased, however, aromatic hydroxythe liver, kidney, pituitary and various organs of the genitourinlation becomes a more dominant pathway for both strains.
ary tract of several species (10) (11) (12) . Induction of tumors in At starting E2 concentrations as low as 3 nM, Spraguemultiple tissues and species strongly supports the IARC Dawley liver microsomes produced comparable yields of classification of estrogens as human carcinogens (13) .
2-hydroxy-E2 and E1. In contrast, ACI liver microsomes
Although estrogens are known mammary carcinogens in yielded a profound shift to aromatic hydroxylation as the animals and humans, the mechanisms of carcinogenesis are dominant pathway as E2 concentrations dropped below 1 not clear. One proposed mechanism is based on the mitogenic µM, and this shift reflected the production of 4-hydroxyaction of estrogens in hormone-specific tissues (i.e. uterus and E2 as the predominant product. The apparent K m for 4-breast) mediated via estrogen receptors (2, 8, 14) . With longer hydroxylation of E2 is <0.8 µM, as opposed to~4 µM periods of enhanced proliferation there is an increased chance for 2-hydroxylation, suggesting that different cytochrome of mutations. Another mechanism has been proposed in which P450s (CYPs) are responsible. Western immunoblotting of estrogens act as direct genotoxic carcinogens (15) . Estrogen the liver microsomal preparations from ACI and Spraguemetabolites are able to covalently bind to DNA and the Dawley rats for CYPs known to catalyze 2-and 4-resulting modified sites in DNA are proposed to be prehydroxylation of E2 revealed that both strains contained mutagenic lesions (11, 16) . The third proposed mechanism of comparable amounts of CYP 2B1/2 and 3A1/2, but no E2 carcinogenicity is that estrogens or their metabolites are detectable amounts of CYP 1B1, the proposed E2 4-indirectly genotoxic. Reactive oxygen species, generated by hydroxylase. Although this enzyme is not a constitutive redox cycling of estrogen metabolites, such as the catechols CYP in Sprague-Dawley rat liver, its presence in ACI liver and hydroquinones, are suggested to be DNA damaging. This could provide a ready explanation for the predominance is thought to occur by oxidation or hydroxylation of the DNA of 4-hydroxy-E2 as a product. The identity of the estradiol to produce pre-mutagenic lesions which can lead to mutations 4-hydroxylase in ACI rat liver and the role of this unique (17, 18) . Finally, an epigenetic mechanism has been proposed reaction in the heightened sensitivity to E2 carcinogenicity based on the induction of aneuploidy which is concurrent with remain to be elucidated.
the emergence of cell transformation (19) (20) (21) . Determination of the primary mechanism of estrogen carcinogenicity will require an appropriate model system. The rat Introduction provides an excellent model for mammary carcinogenesis Estrogens are risk factors for breast cancer in humans.
based on a low spontaneous tumor incidence and efficient Epidemiological evidence indicates that an increase in level induction of tumors by chemical agents (8, 9) . In addition, or duration of exposure to 17β-estradiol (E2) and estrone (E1) chemically induced rat mammary tumors clearly resemble human breast tumors based on their similar morphology and interactions between E2 and the cells and tissues from these
HPLC analysis
two strains we may dissect out critical processes which underlie Analysis of E2 metabolites was performed on a Supelcosil C18 column (5 µm, the pronounced difference in susceptibility to tumor induction. 4 .6 mmϫ25 cm) at 30°C (Supelco, Bellefonte, PA). The elution conditions These critical differences may also illuminate the major mech- mammary carcinogenesis.
Western immunoblot
Liver microsomes (50 µg) were resolved by SDS-PAGE on 4-12% gradient NuPage gels in MOPS buffer. They were then transferred to a PVDF membrane
Materials and methods
(Immobilon-P; Millipore). Non-specific binding was blocked using Trisbuffered saline (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, containing 10% Animals and chemicals non-fat milk) for 1 h at room temperature. The membranes were probed for Sexually immature (6-7-week-old) and sexually mature (12-14-week-old) 2 h at room temperature with polyclonal antibodies for CYP 1B1, 2B1/2 and female Sprague-Dawley and ACI rats were purchased from Harlan Laborat-3A1/2. Antibody binding for CYPs 2B1/2 and 3A1/2 was detected using ories (Indianapolis, IN). [2,4,6,7-3 H]E2 (72 Ci/mmol) and [4-14 C]E2 (54.1 alkaline phosphatase-conjugated anti-rabbit IgG, then visualized using BCIP/ mCi/mmol) were products of New England Nuclear (Boston, MA).
NBT phosphatase substrate. Anti-CYP 1B1 antibody was detected by incuba-E2, E1, 2-hydroxyestradiol (2-OH-E2), 4-hydroxyestradiol (4-OH-E2), E3, tion for 1 h with a horseradish peroxidase-linked donkey anti-rabbit IgG using 2-hydroxyestrone (2-OH-E1), 4-hydroxyestrone (4-OH-E1), 6α-hydroxyestrathe enhanced chemiluminescence method. diol (6α-OH-E2), clotrimazole and all other substrates, enzymes and cofactors were from Sigma Chemical Co. (St Louis, MO). All solvents and reagent chemicals were of HPLC grade and were purchased from Fisher Scientific profiles were observed as the E2 concentration was decreased. was incubated with rat liver microsomes (1 mg microsomal protein/ml) for 20 min with a NADPH generating system. Ethyl acetate extracts were processed and analyzed by reverse phase HPLC as described in Materials and methods. These data were generated using RLM from mature rats. Similar results were obtained with immature animals. These changes are demonstrated by the data in Figure 1 , product distributions, demonstrating that loss of tritium was not a significant factor in our studies (data not shown). showing representative HPLC profiles resulting from E2 metabolism at the high and low ends of this concentration range.
This concentration-dependent shift in the spectrum of metabolites formed by RLM from each strain is shown by the With an initial concentration of 30 µM E2 the major metabolite produced by RLM from both strains was E1, with tabulated product yields (Table I) and by the normalized product distributions (Figure 2 ). The E2 concentrations chosen minor amounts of 2-OH-E2 as the only other detectable product ( Figure 1A and C) . In the Sprague-Dawley preparation for this experiment were 30 µM, a concentration where E1 formation predominates, and 100 nM, where both strains containing 9 nM E2 the major metabolite formed was still E1, but there was a nearly equal contribution of aromatic produced significant yields of both dehydrogenation and hydroxylation products. At 30 µM E2 the major metabolite hydroxylation, specifically formation of 2-OH-E2 and 2/4-hydroxyestrone (CE1) ( Figure 1B) . A more dramatic change produced for both strains and both age groups was E1, accounting for 55-95% of metabolites ( Figure 2A ). 2-OH-E2 in metabolism was seen in the ACI RLM at nanomolar E2 concentrations ( Figure 1D ). At this E2 concentration E1 was is the next most abundant metabolite, ranging from 8% in immature ACI rats to Ͼ40% in mature Sprague-Dawley rats. no longer the major metabolite produced and instead aromatic hydroxylation was the major pathway. Moreover, the predominThe only group that produced detectable 4-OH-E2 at this E2 concentration was the mature ACI rats and this was Ͻ10% of ant catechol estrogen formed was 4-OH-E2, with lesser amounts of 2-OH-E2 and CE1 found. Examination of the total metabolites. At 100 nM E2, E1 remained the major product from Sprague-Dawley microsomes, but fell to 45% kinetics of individual product formation at times from 5 to 20 min incubation showed that 2-OH-E2, 4-OH-E2 and E1 of total metabolites ( Figure 2B ). 2-OH-E2 production remained the same in each strain for each age when the E2 concentration yields increased steadily with incubation time, whereas CE1 formation was only detectable after the 5 min incubation time was decreased. Also, at 100 nM E2 there was production of CE1 by all groups but immature ACI rats. Formation of the (data not shown). This is consistent with their formation as primary and secondary metabolites of E2. Parallel incubations catechol estrones requires two oxidative steps, presumably the conversion of E2 to estrone followed by aromatic hydroxylation were performed with 3 H-and 14 C-labeled E2 at initial substrate concentrations of 0.3, 1 and 10 µM, which produced identical to the catechol. Our HPLC procedure could not resolve Extraction and analysis were as described under Materials and methods and for Figure 1 . Data represent the means Ϯ standard deviations from the analysis of three replicate incubations. Comparison of the rate of individual metabolite formation to the rate observed with the NADPH generating system was performed by one-way ANOVA followed by Dunnett's test. *, Significant difference from NADPH generating system, P Ͻ 0.05.
the catechol estrones 2-OH-E1 and 4-OH-E1, but it could distinguish the catechol estrones from the catechol estradiols 2-OH-E2 and 4-OH-E2. Strikingly, at 100 nM E2 RLM from both age groups of ACI rats produced more 4-OH-E2 than any other metabolite, accounting for 35% of metabolites in mature ACI rats and 70% of metabolites formed in immature ACI rats. It is key to note that the clear qualitative differences in metabolite profile for E2 oxidation are between strains and that only minor quantitative differences are observed between immature and mature female rats of the same strain. The ACI preparations were incubated with various cofactors and inhibitors to determine what enzymes or families of enzymes were responsible for E2 metabolism (Figure 3) . We chose 1 µM E2 as the initial substrate concentration to ensure and 10 µM clotrimazole, a broad CYP inhibitor, showed a Rat liver microsomes (1 mg/ml) were incubated for 20 min with concentrations of [ 3 H]E2 at half-log intervals from 9 nM to 30 µM with a NADPH generating system. All incubations were performed in triplicate. Fig. 4 . Western analysis of cytochrome P450 expression in rat liver Extraction and HPLC analyses were as described under Materials and microsomes. Rat liver microsomes (50 µg) were resolved by SDS-PAGE on methods. Kinetic constants were derived from the data using the kinetics 4-12% gradient gels, transferred to a PVDF membrane and probed with analysis program GraFit v.4.0. ND, not detected. Limit of detection for polyclonal antibodies for CYPs 2B1/2 and 3A1/2 for 2 h at room individual products was 0.3% of the initial E2 concentration and thus temperature. Antibody reactions were detected using alkaline phosphataseranged from 0.0014 pmol/mg/min at 9 nM substrate to 4.5 pmol/mg/min at conjugated anti-rabbit IgG, then visualized using BCIP/NBT phosphatase 30 µM E2.
substrate. SD, Sprague-Dawley; C, control; E2, 17β-estradiol-treated; 6 wk, sexually immature animals; 12 wk, sexually mature animals.
75% decrease in production of 4-OH-E2 and 2-OH-E2, indicating that these are products of CYP-dependent reactions. Also, was performed on the microsomal fractions of each rat strain there was an increase in E1 production, a 17β-hydroxysteroid and each age group to determine the expression level of CYPs dehydrogenase (17β-HSD)-dependent reaction. When the known to be involved in E2 metabolism. Under the conditions cofactor NADP was added without glucose 6-phosphate studied there is expression of CYPs 2B1/2 and 3A1/2 in both dehydrogenase there was a 70% decrease in production of strains of rat ( Figure 4 ). There are no major differences in the 4-OH-E2 and 2-OH-E2, with a corresponding increase in E1 expression of CYP 2B1/2 or 3A1/2 between the two age production. This is consistent with the ability of NADP to groups of ACI rats. Both immature and mature Spragueserve as a cofactor for 17β-HSD (30,31) but not for CYPDawley rats express comparable levels of CYP 2B1/2, but dependent hydroxylation. There was some production of immature Sprague-Dawley rats have diminished 3A1/2 expres-4-OH-E2 and 2-OH-E2, which could be attributed to reduction sion relative to mature rats. In this study we also examined of the NADP to NADPH by 17β-HSD or other microsomal the effect of chronic E2 administration on hepatic CYP dehydrogenases, which could then serve as a cofactor for expression. No effects were detected. This was mirrored by a CYP-dependent metabolism of E2 to the catechols. When lack of detectable effect of E2 treatment on the ability of RLM NAD, a cofactor that cannot be reduced to NADPH, was to metabolize E2 (data not shown). ACI and Sprague-Dawley added there was complete abolition of formation of the catechol RLM were analyzed for expression of CYP 1B1 as well. There estrogens.
was no detectable expression of CYP 1B1, a known estradiol The differences in hydroxylation products formed in the 4-hydroxylase, in RLM from either strain of rat (data not two strains of rats suggests that there are different CYPs shown). present in liver microsomes from these two strains. Different enzymes might be expected to exhibit different kinetic conDiscussion stants. Sprague-Dawley and ACI RLM were incubated for 20 min with E2 concentrations of 0.003, 0.01, 0.03, 0.10, 0.30,
We have demonstrated that liver microsomes from ACI and Sprague-Dawley rats both efficiently metabolize E2 over a 1, 3, 10, 30 and 60 µM. Using graphical analysis of initial rate data, kinetic constants were obtained for the three metabolwide range of initial substrate concentrations. These liver preparations catalyze only aromatic hydroxylation and the ites of interest for ACI and Sprague-Dawley rats (Table II) . Catechol estrones, which result from two sequential enzymatic 17β-dehydrogenation of E2. This is in marked contrast to male Sprague-Dawley liver microsomes, which yield a far more reactions, were not included in the calculation of initial rate, either as distinct products or as contributors to either aromatic complex mixture of oxidized metabolites (G.A.Reed, unpublished observation; 32). Similar metabolite profiles are prohydroxylation of dehydrogenation. We found that the V max and K m for E1 in both rat strains are significantly higher than for duced by RLM from females of the two strains at high initial E2 concentrations (i.e. ജ10 µM), but this changes dramatically aromatic hydroxylation. This is consistent with the known properties of 17β-HSD, a high capacity and relatively high when the substrate concentration is lowered into the nanomolar range. Sprague-Dawley rats yield more 2-OH-E2 relative to K m enzyme for E2 oxidation. Aromatic hydroxylation, however, is catalyzed by CYPs. Second, there is no significant difference E1 as the initial substrate concentration is decreased, but E1 remains the major product. In ACI rats, however, aromatic between the E2 K m value for 2-hydroxylation in SpragueDawley and ACI rats. In contrast, the E2 K m value for hydroxylation dominates and 4-OH-E2 is produced as the predominant metabolite at lower E2 concentrations. 4-hydroxylation in ACI rats is significantly lower than the K m for 2-hydroxylation in ACI rats. These data suggest that the Previous reports on the metabolism of E2 by microsomal preparations and by purified CYPs have employed extremely same CYP may catalyze 2-hydroxylation of E2 in both strains, but that the 4-hydroxylation seen with ACI RLM is catalyzed high substrate concentrations, ranging from 20 to 200 µM (32-34; reviewed in ref. 35). Our qualitative findings at high by a different enzyme.
The search for this different CYP-dependent enzyme was E2 concentrations, i.e. that E1 is the major metabolite formed followed by 2-OH-E2, are consistent with other laboratories carried out by western analysis of RLM. Immunoblot analysis studying E2 metabolism by RLM from female Spragueand it also activates the estrogen receptor (38). 4-OH-E2 takes longer to dissociate from the estrogen receptor compared with Dawley rats and from other strains as well (33, 34) . With microsomes from the ACI rat, however, this qualitative result E2, therefore, there could be increased biological effects of 4-OH-E2 in comparison with E2 (46). COMT-catalyzed changes dramatically, but only when the initial E2 concentration is lowered toward more realistic levels. We have shown that O-methylation is inhibited by 4-OH-E2. Regardless of the mechanism, 4-OH-E2 is important in the carcinogenicity of rat liver microsomes oxidize E2 at low concentrations, nearing actual physiological concentrations. These lower, more physio-E2. It is not surprising that ACI rats, which are more sensitive to E2 as a mammary carcinogen, produce more of this logically relevant concentrations, which have not been examined before, were required in order to observe the dramatic detrimental metabolite 4-OH-E2 than Sprague-Dawley rats at near physiological levels of substrate. differences in metabolite profiles between these two rat strains.
In rats hepatic hydroxylation of E2 to the catechols 2-OHLiver metabolism of E2 is an important first step in understanding the role of metabolism in mammary carcinogenesis. E2 and 4-OH-E2 is catalyzed by CYPs 1A2, 2B1/2, 2C6, 2C11, the 2D family and the 3A family (reviewed in 11,35) .
The liver plays a role in controlling the systemic levels of circulating metabolites. In addition to the liver, however, there Production of 2-OH-E2 by these CYPs greatly exceeds formation of 4-OH-E2, with 80-90% production of 2-OH-E2 and is much interest in the metabolism of E2 in target tissues (35). Our next goal is to investigate the metabolism of E2 in the only 10-20% production of 4-OH-E2. This greater production of 2-OH-E2 reflects the orientation of E2 in the active site of mammary gland to see whether there are differences in the target tissue that may be responsible for the differences in the enzyme. Thus, formation of more 2-OH-E2 than 4-OH-E2 is a consequence of the binding interaction between substrate susceptibility of the two strains of rat. If there are differences in metabolism in the target tissue (the mammary gland) this and CYP and should not be dependent on the concentration of E2. In contrast, human CYP 1B1 is unique in that it is would provide additional support for the role of metabolism of E2 in carcinogenicity. reported to be a specific 4-hydroxylase of E2 (36). The presence of CYP 1B1 as a constitutive enzyme in female ACI In summary, these results reveal that there are dramatic differences in the hepatic metabolism of E2 in ACI and rat liver would be consistent with our observed metabolite profile. By comparing the K m values determined for ACI RLM, Sprague-Dawley rats and that these differences are only apparent as the conditions approach physiological concentrait is apparent that 4-hydroxylation of E2 is catalyzed by a different enzyme with a lower K m than that for 2-hydroxylation.
tions of E2. Since 4-OH-E2 is thought to be the main carcinogenic metabolite of E2, it is even more interesting The K m determined for 4-hydroxylation of E2 in ACI RLM, substantially lower than that determined for 2-hydroxylation that ACI rat liver produces primarily this metabolite when challenged with near physiological levels of E2. The exclusive of E2 in the same incubations, matches the reported E2 K m value for 4-hydroxylation by recombinant human CYP 1B1 formation of this metabolite by the rat strain which is more sensitive to the carcinogenic effects of E2 suggests a role for (36), providing an additional suggestion that this CYP may be responsible for the observed biotransformation of E2.
this difference in E2 disposition in the different responses of the strains. We found, however, that in female ACI rat liver there are no qualitative differences in the CYPs tested from what is expressed in the Sprague-Dawley female liver. There was
